Dr. Cinthia Hurtado Esquen is a physician trained at Universidad Peruana Cayetano Heredia (UPCH), a specialist in Internal Medicine from the Universidad Nacional Mayor de San Marcos (UNMSM), and holds a Master’s degree in Control of Infectious and Tropical Diseases from UPCH.
She currently serves as Coordinator of the Master’s Program in Research Ethics at UPCH and as Director of the Office of Regulatory Affairs for Research at UPCH, where she leads the areas of clinical trials, biosafety, regulation, and responsible conduct of research. She is also a medical auditor and teaches the module Legal and Regulatory Aspects in Clinical Research at Universidad Privada Antenor Orrego.
As a clinical researcher at the Alexander von Humboldt Tropical Medicine Institute (UPCH), she participated in phase II and III tuberculosis studies, including international protocols on rifapentine and drugs for multidrug-resistant tuberculosis.
Between 2014 and 2019, she worked at the National Institute of Health (INS) as an evaluator and inspector of clinical trials and research ethics committees, contributing to the development of national guidelines based on Good Clinical Practices. She was co-author of the official guideline Standards for the Inspection of Clinical Trials – Resolution 072-2019-J-OPE/INS.
Additionally, she was a member of the Working Group on Clinical Trial Contracts convened by the Pan American Health Organization (PAHO), where she contributed to the development of the Regional Model Clinical Trial Agreement.
Her academic work focuses on research ethics and scientific integrity. She has organized and led international workshops on Responsible Conduct of Research at UPCH (2022–2025) and is the author of recent publications in Acta Herediana and the Pan American Journal of Public Health (PAHO).
She has complemented her training with international courses in good clinical practices, research ethics, and clinical trial management at institutions such as Tulane University, the University of Washington, and Harvard University.
Her career combines experience in medicine, auditing, clinical research, regulation, and bioethics, with a strong commitment to protecting research participants, ensuring the integrity of scientific data, and promoting an ethical culture in biomedical research.